Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    EU and US agree critical minerals action plan

    April 27, 2026

    Belvilla and Flying Blue, Loyalty program of Air France-KLM partner to Expand Miles Redemption into Vacation Rentals

    April 20, 2026

    Gavi records US$302 million in lower-income vaccine funding

    April 17, 2026
    Trending
    • EU and US agree critical minerals action plan
    • Belvilla and Flying Blue, Loyalty program of Air France-KLM partner to Expand Miles Redemption into Vacation Rentals
    • Gavi records US$302 million in lower-income vaccine funding
    • Peter Magyar wins Hungary parliamentary vote
    • EU ETS emissions extend decline with 1.3% drop in 2025
    • Moscow launches T2 as longest urban tram line
    • European wheat falls for third session on supply glut
    • EU says Strait of Hormuz navigation must stay toll free
    Liverpool Daily PostLiverpool Daily Post
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Liverpool Daily PostLiverpool Daily Post
    Home » Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s
    Health

    Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s

    November 22, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    In the relentless battle against neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, a groundbreaking discovery emerges from The University of Texas at El Paso. Researchers, exploring the unlikeliest of sources—spent coffee grounds—have unearthed a potential weapon against these debilitating conditions that afflict millions and strain healthcare budgets with hundreds of billions in annual costs.

    Brewing hope - how used coffee grounds may combat Alzheimer's and Parkinson's

    Leading the charge is Jyotish Kumar, a doctoral student in the Department of Chemistry and Biochemistry, along with Mahesh Narayan, Ph.D., a distinguished professor and Royal Society of Chemistry Fellow. Their team has identified caffeic-acid based Carbon Quantum Dots (CACQDs), derivable from used coffee grounds, as a promising agent in shielding brain cells from damage typically associated with neurodegenerative diseases, particularly those exacerbated by factors like obesity, aging, and exposure to environmental toxins.

    Their findings, detailed in the journal Environmental Research, mark a significant leap forward. “CACQDs could revolutionize neurodegenerative disease treatment,” Kumar states. Unlike existing therapies that merely manage symptoms, CACQDs aim at the root causes – the molecular triggers of these ailments. Neurodegenerative diseases, characterized by neuron loss, impair basic and complex functions—from movement and speech to cognitive abilities.

    Lifestyle and environmental factors in early stages of these diseases often lead to increased free radicals and amyloid protein fragment aggregation in the brain, contributing to the progression of these conditions. Kumar’s team discovered that CACQDs offer neuroprotection in various models of Parkinson’s disease, particularly those induced by the pesticide paraquat. The CACQDs demonstrated an ability to neutralize free radicals and prevent amyloid protein aggregation, all without notable side effects.

    This breakthrough suggests that early intervention with CACQD-based treatments could thwart the full onset of diseases like Alzheimer’s and Parkinson’s. Caffeic acid, a polyphenol known for its antioxidant properties, is uniquely capable of crossing the blood-brain barrier, thus directly impacting brain cells. The team’s “green chemistry” approach to extracting CACQDs from coffee waste—cooking grounds at 200° for four hours—is both eco-friendly and cost-effective, making this a sustainable solution.

    The project, encompassing contributions from numerous UTEP graduate and undergraduate students, including Sofia Delgado, now a Ph.D. student at Yale University, signifies a collective effort in scientific advancement. While Narayan and Kumar acknowledge the journey ahead is long, the potential of developing a simple, pill-based preventative treatment for the majority of non-genetically caused neurodegenerative disorders remains a beacon of hope.

    Related Posts

    Gavi records US$302 million in lower-income vaccine funding

    April 17, 2026

    Spruce-derived compounds show anticoagulant promise

    April 8, 2026

    WHO launches science-backed World Health Day 2026 push

    April 7, 2026

    EU launches 225 million euro drive for advanced flu shots

    February 24, 2026

    WHO approves extra nOPV2 for UN backed polio campaigns abroad

    February 14, 2026

    Global analysis ties 7.1 million cancers to modifiable risks

    February 4, 2026
    Editor's Pick

    EU and US agree critical minerals action plan

    April 27, 2026

    Gavi records US$302 million in lower-income vaccine funding

    April 17, 2026

    Peter Magyar wins Hungary parliamentary vote

    April 13, 2026

    EU ETS emissions extend decline with 1.3% drop in 2025

    April 11, 2026

    Moscow launches T2 as longest urban tram line

    April 11, 2026

    European wheat falls for third session on supply glut

    April 11, 2026

    EU says Strait of Hormuz navigation must stay toll free

    April 11, 2026

    UK temperatures to hit 26C before cooler weather returns

    April 8, 2026
    © 2024 Liverpool Daily Post | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.